pretreatment mitochondrial priming correlates clinical response cytotoxic chemotherapy
cytotoxic chemotherapy targets elements common nucleated human cells dna microtubules yet selectively kills tumor cells show clinical response drugs correlates may partially governed pretreatment proximity tumor cell mitochondria apoptotic threshold property called mitochondrial priming used bh3 profiling measure priming tumor cells patients multiple myeloma acute myelogenous lymphoblastic leukemia ovarian cancer assay measures mitochondrial response peptides derived proapoptotic bh3 domains proteins critical death signaling mitochondria patients highly primed cancers exhibited superior clinical response chemotherapy contrast chemoresistant cancers normal tissues poorly primed manipulation mitochondrial priming might enhance efficacy cytotoxic agents
